XMD16-5

Cat. No.: 0225LY-0880

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, HPLC, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: XMD16-5 is an inhibitor of TNK2, a protein whose genomic amplification and disrupted signaling are linked to metastasis and late-stage progression in breast, prostate, lung, and gastrointestinal cancers.

Synonym: 1345098-78-3; 2-[4-(4-hydroxypiperidin-1-yl)anilino]-11-methyl-5H-pyrimido[4,5-b][1,4]benzodiazepin-6-one; Benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one, 18; 2-((4-(4-hydroxypiperidin-1-yl)phenyl)amino)-11-methyl-5,11-dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one; 2-((4-(4-hydroxypiperidin-1-yl)phenyl)amino)-11-methyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one; 3-[4-(4-Hydroxy-piperidin-1-yl)-phenylamino]-5-methyl-5,11-dihydro-2,4,5,11-tetraaza-dibenzo[a,d]cyclohepten-10-one; 5-{[4-(4-hydroxypiperidin-1-yl)phenyl]amino}-2-methyl-2,4,6,9-tetraazatricyclo[9.4.0.0(3),?]pentadeca-1(15),3,5,7,11,13-hexaen-10-one

CAS No.: 1345098-78-3

Compound CID: 57340666

Formula: C₂₃H₂₄N₆O₂

Formula Weight: 416.48